Supply chain management in the pharmaceutical industry in Poland 2008

Table of contents:

Report methodology

Introduction

Executive summary

Model of an excellent supply chain in the pharmaceutical industry

• Basic features of the supply chain
• Stages of SCM advancement
• Scope of research carried out for the purposes of the report

Diagnosis of supply chains of producers in the pharmaceutical industry

• Subjective structure of the supply chain
• Problems identified in the subjective structure of the drug supply chain in Poland
• Most important tendencies in the subjective structure of drug supply chains in Poland
• Objective structure of the supply chain
• Regulations of pharmaceutical products demand and supply
• Innovative and generic medicines
• Rx and OTC medicines
• Problems identified in the objective structure of supply chains in Poland
• Most important trends in the objective structure of drug supply chains in Poland
• Selected processes in the pharmaceutical supply chain
• Supply chain planning – synchronisation of demand and supply
• Customer service
• Physical distribution (transport, storage)
• Manufacturing
• Supplies (relations with suppliers)
• Redistribution – management of returns and waste
• Marketing activities
• Designing and launching new products
• Summary

Survey-based assessment of the level of SCM integration in the pharmaceutical industry in Poland

• Results of the survey carried out amongst companies present on the pharmaceutical market in Poland
• Sample characteristic
• Source of competitive edge in pharmaceutical companies in Poland
• Knowledge of SCM concepts in pharmaceutical companies in Poland
• Assessment of strategic gap in SCM in Poland
• Analysis of best practices – selected directions of improving SCM in the Polish pharmaceutical industry
• SCM strategies in the pharmaceutical industry
• Case study 1 – SCM strategy in Bayer Pharmaceuticals
• Internal SCM conditions in pharmacy (organisational structure supporting SCM)
• Case study 2 – Organisational changes in Becton Dickinson
• Case study 3 – Organisational structure for the Baxter Poland supply chain
• Pharmaceutical supply chain controlled by actual demand
• Case Study 4 – Direct distribution – Poltraf
• Case Study 5 – Joint forecasting and planning in Bayer AG
• Case study 6 – Demand management in the supply chain in Procter & Gamble
• Customer service in the pharmaceutical supply chain
• Case study 7 – Customer service in the supply chain of Procter & Gamble
• Leaning of the pharmaceutical supply chain – manufacturing processes
• Case study 8 – Lean production of copolymer producer
• Integration of suppliers by medicine producers
• Case study 9 – Integration of suppliers in a global pharmaceutical company

Premises and conditions of the development of SCM in the Polish pharmaceutical industry

• SCM and improved company competitiveness
• Opportunities and threats of SCM development in pharmaceutical companies in Poland

Annex 1 Detailed list of answers of respondents – SCM diagnosis in the Polish pharmaceutical industry

List of graphs

List of tables

About PMR

Contact PMR

List of graphs and Tables:

List of graphs

1. Report logics
2. Components of the supply chain management excellence model
3. Subjective structure of the pharmaceutical supply chain in Poland, 2008
4. Example of price structure of non-reimbursed medicine in Poland, 2008
5. Models of medicine distribution on the Polish market, 2008
6. Comparison of traditional and network-based procedure of clinical test data management
7. Place of surveyed companies in the supply chain in the pharmaceutical industry in Poland (number of companies), divided by business, 2008
8. Companies participating in the survey of the pharmaceutical industry in Poland, according to product groups (number of companies), 2008
9. Scope of operations of companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
10. Source of capital in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
11. Area of competitive edge in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
12. Knowledge of SCM concepts in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
13. Position of the supply chain manager in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
14. SCM strategy model in Bayer Pharmaceuticals, 2008
15. Traditional organisational structure of the Becton Dickinson supply chain, until mid 1990s
16. New organisational structure of the Becton Dickinson supply chain, from mid 1990s
17. Matrix organisational structure of the Baxter Polska supply chain, 2008
18. Direct distribution model applied by Poltraf in Poland, 2008
19. SCM goals in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
20. Reduction of the production process duration at the polymer producer
21. Idea of balancing needs of producers and their suppliers proposed within ECR
22. Supplier Development Positioning Matrix

List of tables

1. Soft conditions of the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
2. Hard conditions of the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
3. Management elements – strategic issues in the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
4. Management elements – processes 1 in the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
5. Management elements – processes 2 in the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
6. Availability of individual groups of medicines in subsequent links of the distribution channel in Poland, 2008
7. Place of performance of individual processes in the pharmaceutical supply chain in Poland, 2008
8. SCM advancement levels in the pharmaceutical industry in Poland, soft and hard conditions, 2008
9. Strategic approach in SCM in the pharmaceutical industry in Poland, 2008
10. Advancement of SCM processes in the pharmaceutical industry in Poland, 2008
11. Position of pharmaceutical supply chains in Poland in reference to the excellence model, 2008
12. SCM result card (SCORCARD)
13. Classification of pharmaceutical supply chains
14. Features distinguishing individual types of pharmaceutical supply chains
15. Division of operational costs in the pharmaceutical supply chain in the medical industry in the United States
16. Costs of processes in the supply chain before and after implementation of the EHCR strategy
17. Economies generated by individual solutions of the EHCR strategy
18. Analysis of opportunities and threats for the performance of supply chain management assumptions in a pharmaceutical company in Poland, 2008
19. SCM advancement levels in the pharmaceutical sector in Poland, soft and hard conditions (number of respondents), 2008
20. Strategic approach in SCM in the pharmaceutical industry in Poland (number of respondents), 2008
21. Application of SCM processes in the pharmaceutical industry in Poland (number of respondents), 2008

Download white paper: